Overview
Galois applies formal methods and functional programming to build trustworthy, high-assurance software and hardware for safety-critical systems. Its approach centers on mathematical proofs and verification tools, such as Cryptol for cryptographic specification and the Software Analysis Workbench (SAW) for code verification, rather than relying mainly on tests. The company differentiates itself with a strong research-to-product model, government contracting history (DARPA, DoD, NASA) and spinout ventures that commercialize its technologies. Its goal is to provide mathematically proven, verifiable systems for sectors where failure is not an option, and to advance the field by turning research into market-ready solutions through targeted spinouts.
Work here?Claim your company
Simplify's take
What believers are saying
- DARPA awarded Galois $12.6M for COOP, extending work through 2027.
- NIH awarded Healthydocs on 2026-08-12, opening healthcare cybersecurity beyond defense.
- Galois released SAW 1.5, Cryptol 3.5.0, and CAMET in 2026.
What critics are saying
- GovEagle shows 12-month federal obligations fell to $10.7M, down 70.5%.
- Nine awards worth $126.3M end within 24 months, creating heavy recompete risk.
- If DARPA and NIH recompetes slip in 2027, Galois's research engine shrinks.
What makes Galois unique
- Galois pairs formal verification with cryptography, AI, and systems engineering for critical infrastructure.
- On 2026-11-01, Galois supported IOG Midnight recursive ZK proofs in Halo2.
- Galois converts research into tools like SAW, Cryptol, and spinouts such as MuseDev.
Help us improve and share your feedback! Did you find this helpful?